EP3097212A4 - Verfahren und zusammensetzungen für sequenzen zur führung von cas9-targeting - Google Patents

Verfahren und zusammensetzungen für sequenzen zur führung von cas9-targeting Download PDF

Info

Publication number
EP3097212A4
EP3097212A4 EP15740979.8A EP15740979A EP3097212A4 EP 3097212 A4 EP3097212 A4 EP 3097212A4 EP 15740979 A EP15740979 A EP 15740979A EP 3097212 A4 EP3097212 A4 EP 3097212A4
Authority
EP
European Patent Office
Prior art keywords
compositions
methods
cas9 targeting
sequences
guiding cas9
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP15740979.8A
Other languages
English (en)
French (fr)
Other versions
EP3097212A2 (de
Inventor
Rodolphe Barrangou
Kurt M. SELLE
Alexandra E. BRINER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
North Carolina State University
University of California
Original Assignee
North Carolina State University
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by North Carolina State University, University of California filed Critical North Carolina State University
Publication of EP3097212A2 publication Critical patent/EP3097212A2/de
Publication of EP3097212A4 publication Critical patent/EP3097212A4/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]

Landscapes

  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP15740979.8A 2014-01-24 2015-01-23 Verfahren und zusammensetzungen für sequenzen zur führung von cas9-targeting Pending EP3097212A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461931515P 2014-01-24 2014-01-24
PCT/US2015/012747 WO2015112896A2 (en) 2014-01-24 2015-01-23 Methods and compositions for sequences guiding cas9 targeting

Publications (2)

Publication Number Publication Date
EP3097212A2 EP3097212A2 (de) 2016-11-30
EP3097212A4 true EP3097212A4 (de) 2017-10-04

Family

ID=53682132

Family Applications (1)

Application Number Title Priority Date Filing Date
EP15740979.8A Pending EP3097212A4 (de) 2014-01-24 2015-01-23 Verfahren und zusammensetzungen für sequenzen zur führung von cas9-targeting

Country Status (4)

Country Link
EP (1) EP3097212A4 (de)
JP (4) JP2017503514A (de)
CA (1) CA2936646C (de)
WO (1) WO2015112896A2 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110117622A (zh) * 2019-05-24 2019-08-13 青岛农业大学 一种CRISPR/Cas基因编辑系统及其制备方法和应用

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2853829C (en) 2011-07-22 2023-09-26 President And Fellows Of Harvard College Evaluation and improvement of nuclease cleavage specificity
US20150044192A1 (en) 2013-08-09 2015-02-12 President And Fellows Of Harvard College Methods for identifying a target site of a cas9 nuclease
MX2016002306A (es) 2013-08-22 2016-07-08 Du Pont Promotor u6 de polimerasa iii de soja y metodos de uso.
US9359599B2 (en) 2013-08-22 2016-06-07 President And Fellows Of Harvard College Engineered transcription activator-like effector (TALE) domains and uses thereof
US9737604B2 (en) 2013-09-06 2017-08-22 President And Fellows Of Harvard College Use of cationic lipids to deliver CAS9
US9388430B2 (en) 2013-09-06 2016-07-12 President And Fellows Of Harvard College Cas9-recombinase fusion proteins and uses thereof
US9228207B2 (en) 2013-09-06 2016-01-05 President And Fellows Of Harvard College Switchable gRNAs comprising aptamers
US10584358B2 (en) 2013-10-30 2020-03-10 North Carolina State University Compositions and methods related to a type-II CRISPR-Cas system in Lactobacillus buchneri
CA2930015A1 (en) 2013-11-07 2015-05-14 Editas Medicine, Inc. Crispr-related methods and compositions with governing grnas
US11053481B2 (en) 2013-12-12 2021-07-06 President And Fellows Of Harvard College Fusions of Cas9 domains and nucleic acid-editing domains
WO2015112896A2 (en) * 2014-01-24 2015-07-30 North Carolina State University Methods and compositions for sequences guiding cas9 targeting
CA2944978C (en) 2014-04-08 2024-02-13 North Carolina State University Methods and compositions for rna-directed repression of transcription using crispr-associated genes
US10077453B2 (en) 2014-07-30 2018-09-18 President And Fellows Of Harvard College CAS9 proteins including ligand-dependent inteins
US10450584B2 (en) 2014-08-28 2019-10-22 North Carolina State University Cas9 proteins and guiding features for DNA targeting and genome editing
BR112017017260A2 (pt) 2015-03-27 2018-04-17 Du Pont construções de dna, vetor, célula, plantas, semente, método de expressão de rna e método de modificação de local alvo
MX2017014561A (es) * 2015-05-15 2018-03-02 Pioneer Hi Bred Int Nuevos sistemas de arn guia/endonucleasa cas.
EP4039816A1 (de) 2015-05-29 2022-08-10 North Carolina State University Verfahren zum screening von bakterien, archaea, algen und hefe mit crispr-nukleinsäuren
JP7051438B2 (ja) 2015-06-15 2022-04-11 ノース カロライナ ステート ユニバーシティ 核酸およびｒｎａに基づく抗菌剤の効率的な送達のための方法および組成物
US9580727B1 (en) 2015-08-07 2017-02-28 Caribou Biosciences, Inc. Compositions and methods of engineered CRISPR-Cas9 systems using split-nexus Cas9-associated polynucleotides
EP3356533A1 (de) 2015-09-28 2018-08-08 North Carolina State University Verfahren und zusammensetzungen für sequenzspezifische antimikrobielle mittel
IL294014B2 (en) 2015-10-23 2024-07-01 Harvard College Nucleobase editors and their uses
WO2017112620A1 (en) 2015-12-22 2017-06-29 North Carolina State University Methods and compositions for delivery of crispr based antimicrobials
CN105594664B (zh) * 2016-02-16 2018-10-02 湖南师范大学 一种基因敲除选育stat1a基因缺失型斑马鱼的方法
IL308426A (en) 2016-08-03 2024-01-01 Harvard College Adenosine nuclear base editors and their uses
US11661590B2 (en) 2016-08-09 2023-05-30 President And Fellows Of Harvard College Programmable CAS9-recombinase fusion proteins and uses thereof
US11542509B2 (en) 2016-08-24 2023-01-03 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
SG11201903089RA (en) 2016-10-14 2019-05-30 Harvard College Aav delivery of nucleobase editors
WO2018119359A1 (en) 2016-12-23 2018-06-28 President And Fellows Of Harvard College Editing of ccr5 receptor gene to protect against hiv infection
TW201839136A (zh) 2017-02-06 2018-11-01 瑞士商諾華公司 治療血色素異常症之組合物及方法
US11898179B2 (en) 2017-03-09 2024-02-13 President And Fellows Of Harvard College Suppression of pain by gene editing
EP3592777A1 (de) 2017-03-10 2020-01-15 President and Fellows of Harvard College Cytosin-zu-guanin-baseneditor
JP7191388B2 (ja) 2017-03-23 2022-12-19 プレジデント アンド フェローズ オブ ハーバード カレッジ 核酸によってプログラム可能なｄｎａ結合蛋白質を含む核酸塩基編集因子
US11560566B2 (en) 2017-05-12 2023-01-24 President And Fellows Of Harvard College Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
WO2018217981A1 (en) 2017-05-26 2018-11-29 North Carolina State University Altered guide rnas for modulating cas9 activity and methods of use
US11866726B2 (en) 2017-07-14 2024-01-09 Editas Medicine, Inc. Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites
CN111801345A (zh) 2017-07-28 2020-10-20 哈佛大学的校长及成员们 使用噬菌体辅助连续进化(pace)的进化碱基编辑器的方法和组合物
US11319532B2 (en) 2017-08-30 2022-05-03 President And Fellows Of Harvard College High efficiency base editors comprising Gam
CN111757937A (zh) 2017-10-16 2020-10-09 布罗德研究所股份有限公司 腺苷碱基编辑器的用途
KR102465067B1 (ko) * 2018-02-15 2022-11-10 시그마-알드리치 컴퍼니., 엘엘씨 진핵 게놈 변형을 위한 조작된 cas9 시스템
WO2019165168A1 (en) * 2018-02-23 2019-08-29 Pioneer Hi-Bred International, Inc. Novel cas9 orthologs
EP3861120A4 (de) 2018-10-01 2023-08-16 North Carolina State University Rekombinantes typ-i-crispr-cas-system
CN113166744A (zh) 2018-12-14 2021-07-23 先锋国际良种公司 用于基因组编辑的新颖crispr-cas系统
WO2020191243A1 (en) 2019-03-19 2020-09-24 The Broad Institute, Inc. Methods and compositions for editing nucleotide sequences
WO2020263773A1 (en) * 2019-06-24 2020-12-30 North Carolina State University Methods and compositions for modifying bacterial genomes and for killing bacteria
WO2021216772A1 (en) * 2020-04-21 2021-10-28 Mammoth Biosciences, Inc. Casy programmable nucleases and rna component systems
DE112021002672T5 (de) 2020-05-08 2023-04-13 President And Fellows Of Harvard College Vefahren und zusammensetzungen zum gleichzeitigen editieren beider stränge einer doppelsträngigen nukleotid-zielsequenz

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013176772A1 (en) * 2012-05-25 2013-11-28 The Regents Of The University Of California Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013188638A2 (en) 2012-06-15 2013-12-19 The Regents Of The University Of California Endoribonucleases and methods of use thereof
WO2015112896A2 (en) * 2014-01-24 2015-07-30 North Carolina State University Methods and compositions for sequences guiding cas9 targeting

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013176772A1 (en) * 2012-05-25 2013-11-28 The Regents Of The University Of California Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110117622A (zh) * 2019-05-24 2019-08-13 青岛农业大学 一种CRISPR/Cas基因编辑系统及其制备方法和应用

Also Published As

Publication number Publication date
JP2024041934A (ja) 2024-03-27
JP2022106883A (ja) 2022-07-20
WO2015112896A9 (en) 2015-11-26
WO2015112896A2 (en) 2015-07-30
CA2936646C (en) 2024-04-30
CA2936646A1 (en) 2015-07-30
JP2017503514A (ja) 2017-02-02
WO2015112896A3 (en) 2015-10-29
JP7429057B2 (ja) 2024-02-07
EP3097212A2 (de) 2016-11-30
JP2020103295A (ja) 2020-07-09

Similar Documents

Publication Publication Date Title
EP3097212A4 (de) Verfahren und zusammensetzungen für sequenzen zur führung von cas9-targeting
EP3355954A4 (de) Freisetzungsverfahren und zusammensetzungen
EP3328377A4 (de) Zusammensetzungen und verfahren für immun-onkologie-therapien
EP3151846A4 (de) Verfahren und zusammensetzungen zur nukleasekonstruktion
EP3190894A4 (de) Mikrobielle zusammensetzungen und verfahren
EP3110945A4 (de) Zusammensetzungen und verfahren zur stellengerichteten genommodifikation
EP3288387A4 (de) Mikrobielle zusammensetzungen und verfahren für bioprotektion
EP3152222A4 (de) Zusammensetzungen und verfahren zur abzielung auf einen pfad
EP3307296A4 (de) Verfahren und zusammensetzungen zur behandlung von altersassoziierten leiden
EP3200815A4 (de) Verfahren und zusammensetzungen zur behandlung von krebs
EP3200802A4 (de) Zusammensetzungen und verfahren zur aufrechterhaltung der kognitiven funktion
EP3229849A4 (de) Additivzusammensetzungen für pigmentierte desinfektion und verfahren dafür
IL246879B (en) Preparations of Epilimod and methods of using them
EP3139928A4 (de) Anordrin-zusammensetzungen und verfahren zur behandlung von krankheiten
EP3442543A4 (de) Zusammensetzungen und verfahren für neurogenese
EP3394272A4 (de) Zusammensetzungen und verfahren für effiziente abzielung auf transgene
EP3324932A4 (de) Zusammensetzungen und verfahren für lyophile nanopartikelformen
EP3347025A4 (de) Verfahren und zusammensetzungen zur krebsbehandlung
EP3110446A4 (de) Verfahren und zusammensetzungen zur behandlung von siglec-8-assoziierten krankheiten
EP3253389A4 (de) Apilimodzusammensetzungen und verfahren zur verwendung davon
EP3253403A4 (de) Verfahren und zusammensetzungen für verbesserte kognition
EP3198275A4 (de) Sterilisationszusammensetzungen und verfahren
EP3148564A4 (de) Verfahren und zusammensetzungen zur immunmodulation
EP3002312B8 (de) Härtbare zusammensetzungen
EP3185910A4 (de) Verfahren und zusammensetzungen zur krebsbehandlung

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20160824

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

RIN1 Information on inventor provided before grant (corrected)

Inventor name: SELLE, KURT M.

Inventor name: BARRANGOU, RODOLPHE

Inventor name: BRINER, ALEXANDRA E.

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20170831

RIC1 Information provided on ipc code assigned before grant

Ipc: C12N 15/85 20060101ALI20170825BHEP

Ipc: C12N 15/113 20100101ALI20170825BHEP

Ipc: C12N 15/00 20060101ALI20170825BHEP

Ipc: C07H 21/04 20060101ALI20170825BHEP

Ipc: A61K 48/00 20060101ALI20170825BHEP

Ipc: C12P 19/34 20060101ALI20170825BHEP

Ipc: C12Q 1/68 20060101AFI20170825BHEP

Ipc: C12N 9/16 20060101ALI20170825BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20181030

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS